SCHEMBL24955832

SCHEMBL24955832

Cn1cc(-c2ccccc2)nc1C#Cc1nc(N2CC3(COC3)C2)c2cnn(CC3CNC3)c2n1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 5/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24955831 0.89 SRC (0.39) PDE10A
SCHEMBL30202159 0.85 PDE10A (0.37) PDE10A
SCHEMBL30202254 0.81 PIK3CA (0.40)
SCHEMBL30202391 0.80 PDE10A (0.35) PDE10A
SCHEMBL30203054 0.76 CNR2 (0.38) PDE10A
SCHEMBL24956793 0.76 MTOR (0.41) PDE10A
SCHEMBL24956790 0.73 PIK3CA (0.42) PDE10A
SCHEMBL24955834 0.72 MEN1 (0.43) PDE10A
SCHEMBL30202075 0.72 PDE10A (0.37) PDE10A
SCHEMBL24956792 0.72 PDE10A (0.35) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4377313-A1 IMIDAZOLE ORGANIC COMPOUNDS AND THEIR USE AGAINST INFLAMMATORY BOWEL DISEASE BenevolentAI Cambridge Limited (GB) 2024-06-05 EP claimed
WO-2023007185-A1 IMIDAZOLE ORGANIC COMPOUNDS AND THEIR USE AGAINST INFLAMMATORY BOWEL DISEASE Benevolentai Cambridge Limited (GB) 2023-02-02 WO claimed
EP-4377313-A1 IMIDAZOLE ORGANIC COMPOUNDS AND THEIR USE AGAINST INFLAMMATORY BOWEL DISEASE BenevolentAI Cambridge Limited (GB) 2024-06-05 EP disclosed
WO-2023007185-A1 IMIDAZOLE ORGANIC COMPOUNDS AND THEIR USE AGAINST INFLAMMATORY BOWEL DISEASE Benevolentai Cambridge Limited (GB) 2023-02-02 WO disclosed
WO-2023007185-A1 IMIDAZOLE ORGANIC COMPOUNDS AND THEIR USE AGAINST INFLAMMATORY BOWEL DISEASE Benevolentai Cambridge Limited (GB) 2023-02-02 WO disclosed